MedTrace Logo

Comparison of Two Treatment Regimens of Helicobacter Pylori Infection

NCT07021729 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2025-06-15

No results posted yet for this study

Summary

The goal of this interventional study is to compare the efficacy of clarithromycin Vs levofloxacin based regimen in treatment of Helicobacter pylori infection in patients presenting to medical OPD who are tested positive for H pylori infection.. The main question\[s\] it aims to answer are:

• Which regimen is superior in terms of efficacy Participants will be treated for H pylori Infection in with two different regimen If there is a comparison group: Researchers will compare two groups Group 1 will receive clarithromycin based regimen group 2 will receive levofloxacin based regimen to see the treatment response.

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

Clarithromycin

Drug regimens will be given for 14 days, and omeprazole for 6weeks

DRUG

Levofloxacin

Drug regimens will be given for 14 days, and omeprazole for 6weeks

Sponsors & Collaborators

  • Rehman Medical Institute - RMI

    lead OTHER

Principal Investigators

  • Wajeeha Qayyum, FCPS · Rehman Medical Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2026-03-31
Completion
2026-06-30
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07021729 on ClinicalTrials.gov